MBIO

#5005
Mustang Bio, Inc.
0.7536 USD
-0.84%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.7536
0.7819
Year Range
0.6774
1.0400
Daily Change
-0.84%
Monthly Change
+4.67%
6 month change
-13.18%
Year Change
-13.18%
Previous Close
0.7600
Open
0.7819
Low
0.7536
High
0.7819
Volume
2
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 5.4558 M
  • Employee 4
  • Founded 2015
  • CEO Manuel Litchman
  • Website www.mustangbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00FXTN420
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Mustang Bio Inc

Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency.

News